Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer's disease.
Mattsson-Carlgren N, Andersson E, Janelidze S, Ossenkoppele R, Insel P, Strandberg O, Zetterberg H, Rosen HJ, Rabinovici G, Chai X, Blennow K, Dage JL, Stomrud E, Smith R, Palmqvist S, Hansson O. Mattsson-Carlgren N, et al. Sci Adv. 2020 Apr 15;6(16):eaaz2387. doi: 10.1126/sciadv.aaz2387. eCollection 2020 Apr. Sci Adv. 2020. PMID: 32426454 Free PMC article.
Serum GFAP and UCH-L1 for the prediction of neurological outcome in comatose cardiac arrest patients.
Ebner F, Moseby-Knappe M, Mattsson-Carlgren N, Lilja G, Dragancea I, Undén J, Friberg H, Erlinge D, Kjaergaard J, Hassager C, Wise MP, Kuiper M, Stammet P, Wanscher M, Horn J, Ullén S, Cronberg T, Nielsen N. Ebner F, et al. Resuscitation. 2020 Sep;154:61-68. doi: 10.1016/j.resuscitation.2020.05.016. Epub 2020 May 21. Resuscitation. 2020. PMID: 32445783 Free article.
Performance of a guideline-recommended algorithm for prognostication of poor neurological outcome after cardiac arrest.
Moseby-Knappe M, Westhall E, Backman S, Mattsson-Carlgren N, Dragancea I, Lybeck A, Friberg H, Stammet P, Lilja G, Horn J, Kjaergaard J, Rylander C, Hassager C, Ullén S, Nielsen N, Cronberg T. Moseby-Knappe M, et al. Intensive Care Med. 2020 Oct;46(10):1852-1862. doi: 10.1007/s00134-020-06080-9. Epub 2020 Jun 3. Intensive Care Med. 2020. PMID: 32494928 Free PMC article.
Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders.
Palmqvist S, Janelidze S, Quiroz YT, Zetterberg H, Lopera F, Stomrud E, Su Y, Chen Y, Serrano GE, Leuzy A, Mattsson-Carlgren N, Strandberg O, Smith R, Villegas A, Sepulveda-Falla D, Chai X, Proctor NK, Beach TG, Blennow K, Dage JL, Reiman EM, Hansson O. Palmqvist S, et al. JAMA. 2020 Aug 25;324(8):772-781. doi: 10.1001/jama.2020.12134. JAMA. 2020. PMID: 32722745 Free PMC article.
Comparing progression biomarkers in clinical trials of early Alzheimer's disease.
Cullen NC, Zetterberg H, Insel PS, Olsson B, Andreasson U; Alzheimer’s Disease Neuroimaging Initiative; Blennow K, Hansson O, Mattsson-Carlgren N. Cullen NC, et al. Ann Clin Transl Neurol. 2020 Sep;7(9):1661-1673. doi: 10.1002/acn3.51158. Epub 2020 Aug 11. Ann Clin Transl Neurol. 2020. PMID: 32779869 Free PMC article.
Plasma phosphorylated tau181 and neurodegeneration in Alzheimer's disease.
Hansson O, Cullen N, Zetterberg H; Alzheimer’s Disease Neuroimaging Initiative; Blennow K, Mattsson-Carlgren N. Hansson O, et al. Ann Clin Transl Neurol. 2021 Jan;8(1):259-265. doi: 10.1002/acn3.51253. Epub 2020 Nov 29. Ann Clin Transl Neurol. 2021. PMID: 33249783 Free PMC article.
128 results